In one of the largest settlements ever regarding controlled substance record-keeping violations by a retail pharmacy chain, CVS Pharmacy Inc., and one of its subsidiaries, Oklahoma CVS Pharmacy LLC, (“CVS”) agreed to pay $11 million to the United States. This settlement resolves allegations that CVS violated the record-keeping violations of the Controlled Substances Act and its associated regulations.
Specifically, the U.S. alleged that CVS violated the Controlled Substances Act by: (1) filing prescriptions for prescribers whose DEA registration numbers were not valid or current (2) creating, entering, and maintaining “dummy” DEA registration numbers on dispensing records (including those provided to state drug monitoring programs), and (3) entering and maintaining CVS dispensing records in which the DEA registration number of a non-prescribing practitioner was substituted for the DEA registration of the actual prescribing practitioner.
To resolve these claims, CVS agreed to pay $11 million to the U.S. to settle civil penalties and agreed that its stored would comply with the record-keeping provisions of the CSA. The case was investigated by the DEA’s Office of Diversion Control and was prosecuted and settled by Assistant U.S. Attorney Ronald R. Gallegos and the Department of Justice Criminal Divisions’ Narcotic and Dangerous Drug Section.
For more information, please see: